$2.5T
Total marketcap
$76.65B
Total volume
BTC 50.91%     ETH 15.11%
Dominance

Heska HSKA Stock

119.99 USD {{ price }} 0.000000% {{change_pct}}%
Exchange
NasdaqCM
Market Cap
1.31B USD
LOW - HIGH [24H]
0.0000 - 0.0000 USD
VOLUME [24H]
0 USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

Heska Price Chart

Heska HSKA Financial and Trading Overview

Heska stock price 119.99 USD
Previous Close 119.99 USD
Open 119.96 USD
Bid 119.99 USD x 1400
Ask 120 USD x 1300
Day's Range 119.99 - 119.99 USD
52 Week Range 57.83 - 120.03 USD
Volume 330.89K USD
Avg. Volume 340.75K USD
Market Cap 1.31B USD
Beta (5Y Monthly) 1.599225
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date September 26, 2012
1y Target Est 130 USD

HSKA Valuation Measures

Enterprise Value 1.29B USD
Trailing P/E N/A
Forward P/E 799.9333
PEG Ratio (5 yr expected) -5.71
Price/Sales (ttm) 5.1377344
Price/Book (mrq) 3.1359277
Enterprise Value/Revenue 5.078
Enterprise Value/EBITDA -138.808

Trading Information

Heska Stock Price History

Beta (5Y Monthly) 1.599225
52-Week Change 42.45%
S&P500 52-Week Change 20.43%
52 Week High 120.03 USD
52 Week Low 57.83 USD
50-Day Moving Average 117.59 USD
200-Day Moving Average 87.26 USD

HSKA Share Statistics

Avg. Volume (3 month) 340.75K USD
Avg. Daily Volume (10-Days) 346.35K USD
Shares Outstanding 10.91M
Float 10.29M
Short Ratio 5.41
% Held by Insiders 6.45%
% Held by Institutions 87.54%
Shares Short 1.32M
Short % of Float 16.75%
Short % of Shares Outstanding 12.06%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:10

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -7.85%
Operating Margin (ttm) -9.40%
Gross Margin 42.92%
EBITDA Margin -3.65%

Management Effectiveness

Return on Assets (ttm) -2.50%
Return on Equity (ttm) -4.73%

Income Statement

Revenue (ttm) 254.89M USD
Revenue Per Share (ttm) 24.57 USD
Quarterly Revenue Growth (yoy) -3.69%
Gross Profit (ttm) 111.17M USD
EBITDA -9324000 USD
Net Income Avi to Common (ttm) -20028000 USD
Diluted EPS (ttm) -1.92
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 125.21M USD
Total Cash Per Share (mrq) 11.47 USD
Total Debt (mrq) 109.92M USD
Total Debt/Equity (mrq) 26.32 USD
Current Ratio (mrq) 5.641
Book Value Per Share (mrq) 38.263

Cash Flow Statement

Operating Cash Flow (ttm) -13309000 USD
Levered Free Cash Flow (ttm) -5779625 USD

Profile of Heska

Country United States
State CO
City Loveland
Address 3760 Rocky Mountain Avenue
ZIP 80538
Phone 970 493 7272
Website https://www.heska.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 808

Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was incorporated in 1988 and is based in Loveland, Colorado.

Q&A For Heska Stock

What is a current HSKA stock price?

Heska HSKA stock price today per share is 119.99 USD.

How to purchase Heska stock?

You can buy HSKA shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Heska?

The stock symbol or ticker of Heska is HSKA.

Which industry does the Heska company belong to?

The Heska industry is Medical Devices.

How many shares does Heska have in circulation?

The max supply of Heska shares is 10.91M.

What is Heska Price to Earnings Ratio (PE Ratio)?

Heska PE Ratio is 0.00000000 now.

What was Heska earnings per share over the trailing 12 months (TTM)?

Heska EPS is 0 USD over the trailing 12 months.

Which sector does the Heska company belong to?

The Heska sector is Healthcare.

Heska HSKA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16175.09 USD
-1.62
3.94B USD 16125.33 USD 16341.46 USD 3.94B USD
NASDAQ Composite Total Return I XCMP 19659.36 USD
-1.62
19598.88 USD 19861.56 USD
NASDAQ Capital Market Composite RCMP 114.55 USD
-2.27
114.09 USD 116.72 USD
NASDAQ HealthCare IXHC 958.68 USD
-2.07
954.08 USD 972.42 USD